β-Catenin and adenomatous polyposis coli (APC) mutations in adenomas from hereditary non-polyposis colorectal cancer patients

被引:21
作者
Akiyama, Y
Nagasaki, H
Yagi, KO
Nomizu, T
Yuasa, Y
机构
[1] Tokyo Med & Dent Univ, Sch Med, Dept Hyg & Oncol, Bunkyo Ku, Tokyo 1138519, Japan
[2] Univ Sao Paulo, Sch Med, Dept Gastroenterol, BR-05403000 Sao Paulo, Brazil
[3] Hoshi Gen Hosp, Dept Surg, Fukushima 9638501, Japan
关键词
adenoma; antigen presenting cell; beta-Catenin; hereditary non-polyposis colorectal cancer; microsatellite instability; transforming growth factor-beta Type II receptor;
D O I
10.1016/S0304-3835(00)00486-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To clarify the roles of the adenomatous polyposis coli (APC) and beta -catenin genes in hereditary nonpolyposis colorectal cancer (HNPCC) tumorigenesis, we searched for their mutations in 14 HNPCC adenomas with microsatellite instability (MSI). Seven (50%) adenomas exhibited somatic APC mutations, five of which were frameshift mutations and the other two nonsense ones. However, the APC mutational spectrum of these adenomas was similar to that of sporadic colorectal tumors. Two adenomas (14.3%) with undetectable APC alterations showed missense mutations at codon 45 (TCT to TTT or to CCT) in beta -catenin. The MSI frequency in adenomas with beta -catenin mutations was significantly higher than that with APCones (P < 0.001), indicating that mutations of <beta>-catenin rather than APC are strongly associated with MSI. These data suggest that adenomas with beta -catenin activating mutations and some with APC inactivating mutations may be precursors of HNPCC colorectal cancers. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 32 条
  • [1] Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer
    Akiyama, Y
    Iwanaga, R
    Saitoh, K
    Shiba, K
    Ushio, K
    Ikeda, E
    Iwama, T
    Nomizu, T
    Yuasa, Y
    [J]. GASTROENTEROLOGY, 1997, 112 (01) : 33 - 39
  • [2] Akiyama Y, 1997, CANCER RES, V57, P3920
  • [3] Boland CR, 1998, CANCER RES, V58, P5248
  • [4] The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of β-catenin-lymphocyte enhancer-binding factor signaling
    Easwaran, V
    Song, V
    Polakis, P
    Byers, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) : 16641 - 16645
  • [5] Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences
    Fujiwara, T
    Stolker, JM
    Watanabe, T
    Rashid, A
    Longo, P
    Eshleman, JR
    Booker, S
    Lynch, HT
    Jass, JR
    Green, JS
    Kim, H
    Jen, J
    Vogelstein, B
    Hamilton, SR
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (04) : 1063 - 1078
  • [6] Grady WM, 1998, CANCER RES, V58, P3101
  • [7] Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene
    Harada, N
    Tamai, Y
    Ishikawa, T
    Sauer, B
    Takaku, K
    Oshima, M
    Taketo, MM
    [J]. EMBO JOURNAL, 1999, 18 (21) : 5931 - 5942
  • [8] Identification of c-MYC as a target of the APC pathway
    He, TC
    Sparks, AB
    Rago, C
    Hermeking, H
    Zawel, L
    da Costa, LT
    Morin, PJ
    Vogelstein, B
    Kinzler, KW
    [J]. SCIENCE, 1998, 281 (5382) : 1509 - 1512
  • [9] Mouse models for colorectal cancer
    Heyer, J
    Yang, K
    Lipkin, M
    Edelmann, W
    Kucherlapati, R
    [J]. ONCOGENE, 1999, 18 (38) : 5325 - 5333
  • [10] β-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection
    Huang, H
    Fujii, H
    Sankila, A
    Mahler-Araujo, BM
    Matsuda, M
    Cathomas, G
    Ohgaki, H
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) : 1795 - 1801